Publications
- Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis2021 | First Faculty of Medicine
- Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis2021 | First Faculty of Medicine
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | First Faculty of Medicine
- Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients2017 | First Faculty of Medicine
- Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later2016 | First Faculty of Medicine
- Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a2015 | First Faculty of Medicine
- Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome2015 | First Faculty of Medicine
- Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients2015 | First Faculty of Medicine
- MRI correlates of disability progression in patients with CIS over 48 months2014 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome2014 | First Faculty of Medicine
Loading network view...